The growing number of patients suffering from long-term complications of COVID-19 has spurred the creation of Northwestern Medicine’s Comprehensive COVID-19 Center, which provides coordinated, multidisciplinary care.
A new study shows that two months after the second Pfizer/Moderna vaccination, antibody response decreases 20 percent in adults with prior cases of COVID-19 and examines how current vaccines resist emerging variants.
Northwestern Medicine scientists continue to investigate all aspects of the COVID-19 pandemic: from molecular mechanisms of infection, to child hospitalization and single-dose vaccine response.
A new combination COVID-19 vaccine improved protection against breakthrough infections in mice, according to a recent Northwestern Medicine study.
In collaboration with Northwestern Medicine investigators, an international multi-center study has identified genetic factors associated with SARS-CoV-2 infection and COVID-19 severity.
Inhibiting a specific protein complex in SARS-CoV-2, the virus that causes COVID-19, may be a promising therapeutic target for treating the disease, according to a Northwestern Medicine study.
The Northwestern Medicine Comprehensive COVID-19 Center is committed to caring for and conducting research on behalf of patients who experience long-term complications from COVID-19.
Casey Benzaken, a second-year dual degree MD/MPH student, is studying the attitudes towards flu vaccines of Northwestern University undergraduates.
Members of the Northwestern University Feinberg School of Medicine community have been stepping forward to be vaccinated against COVID-19. Watch videos with three members of Feinberg labs who detail why they chose to get the COVID-19 vaccine.
Northwestern Medicine investigators continue to assess COVID-19 treatments for mild to severe cases, the widespread adoption of telemedicine, and why a “return to normal” will be a missed opportunity to improve healthcare.